A detailed history of T. Rowe Price Investment Management, Inc. transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,556,023 shares of CNTA stock, worth $62.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,556,023
Previous 833,993 326.39%
Holding current value
$62.3 Million
Previous $7.53 Million 655.03%
% of portfolio
0.03%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.58 - $16.99 $23.4 Million - $46.2 Million
2,722,030 Added 326.39%
3,556,023 $56.9 Million
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $6.71 Million - $9.9 Million
833,993 New
833,993 $7.53 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.65B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track T. Rowe Price Investment Management, Inc. Portfolio

Follow T. Rowe Price Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.